Dr. Daniel Vreeman Named Chief AI Officer to Drive Organization's Strategic AI Agenda
HL7 has launched an Artificial Intelligence (AI) Office to establish foundational standards for safe, trustworthy AI in healthcare and convene the global community driving this transformation.
The new office positions HL7 at the forefront of healthcare's AI revolution, creating frameworks that ensure emerging technologies are trusted, explainable, interoperable, and scalable across clinical, operational, and research settings worldwide.
"Artificial intelligence will fundamentally reshape healthcare delivery, evaluation, and payment," said Charles Jaffe, MD, PhD, CEO of HL7 International. "Our new AI Office positions HL7 as the trusted global convener for responsible, standards-driven AI innovation—ensuring these transformative technologies deliver on their promise to improve health for all."
To lead this initiative, HL7 has appointed Daniel Vreeman, DPT, as its first Chief AI Officer (CAIO). Dr. Vreeman will expand his current role as Chief Standards Development Officer to drive HL7's comprehensive AI strategy, including the HL7 AI Challenge, anti-fraud initiatives, and collaborations with regulators and industry partners globally.